There are many powerful catalysts in the market: Nutex Health Inc. (NUTX) can be one of them

Nutex Health Inc. (NASDAQ: NUTX) closed the day trading at $1.07 down -5.31% from the previous closing price of $1.13. In other words, the price has decreased by -$0.0600 from its previous closing price. On the day, 3025249 shares were traded. NUTX stock price reached its highest trading level at $1.1400 during the session, while it also had its lowest trading level at $1.0400.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".



For a better understanding of NUTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 2.57 whereas as Long-Term Debt/Eq ratio is at 2.36.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Northland Capital on February 22, 2023, initiated with a Outperform rating and assigned the stock a target price of $3.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 when Premier Macy Management Holdin sold 43,880 shares for $2.06 per share. The transaction valued at 90,560 led to the insider holds 41,964,832 shares of the business.

Premier Macy Management Holdin sold 125,498 shares of NUTX for $276,773 on Dec 12. The 10% Owner now owns 42,008,712 shares after completing the transaction at $2.21 per share.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 3.87 while its Price-to-Book (P/B) ratio in mrq is 7.13.

Stock Price History:

Over the past 52 weeks, NUTX has reached a high of $52.80, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 1.4289, while the 200-Day Moving Average is calculated to be 2.3785.

Shares Statistics:

Over the past 3-months, NUTX traded about 1.52M shares per day on average, while over the past 10 days, NUTX traded about 1.94M shares per day. A total of 650.15M shares are outstanding, with a floating share count of 321.69M. Insiders hold about 0.10% of the company’s shares, while institutions hold 1.30% stake in the company. Shares short for NUTX as of Jan 12, 2023 were 7M with a Short Ratio of 6.83M, compared to 2.91M on Dec 14, 2022.

Earnings Estimates

Current recommendations for the stock of the company come from 1 analysts. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.

Analysts are recommending an EPS of between -$0.67 and -$0.67 for the fiscal current year, implying an average EPS of -$0.67. EPS for the following year is $0, with 1 analysts recommending between $0 and $0.

Revenue Estimates

Based on 1 analysts’ estimates, the company’s revenue will be $290.2M in the next fiscal year. The high estimate is $290.2M and the low estimate is $290.2M. The average revenue growth estimate for next year is up 34.20% from the average revenue estimate for this year.